NeuralClinic Ai is building an AI-powered clinical intelligence platform for developmental care, designed to support pediatricians, developmental pediatricians, psychiatrists, psychologists, therapists, SLPs, OTs, and families across the care journey.
Our platform is designed around a continuous workflow:
Assessment → Clinical Care → Therapy → Home → School → Longitudinal Progress
The objective is to connect fragmented information across developmental-care settings and support clinicians with structured, data-driven workflows.

1. Clinical Engagement & Market Validation
40+ Clinicians and therapist Engaged in Kochi
In September 2026, NeuralClinic Ai conducted a live product demonstration in Kochi with 40+ Clinicians and therapists.
NeuralClinic Ai is building an AI-powered clinical intelligence platform for developmental care, designed to support pediatricians, developmental pediatricians, psychiatrists, psychologists, therapists, SLPs, OTs, and families across the care journey.







The demonstration covered:
- AI-assisted developmental screening
- Therapy planning
- Longitudinal care management
- Clinical workflow applications
The engagement generated discussions around potential clinical applications, product adoption, and collaboration opportunities.
Growing Provider Pipeline

2. Expanding Clinical Collaboration Network
NeuralClinic Ai is expanding its clinical network through engagement with specialists across developmental pediatrics,
pediatric neurology, child psychiatry, and primary care.
India

Dr. Davidson Devasia, Pediatric Neurologist- Kochi

Dr. Konda Poojitha Reddy, Child & Adolescent Psychiatrist; General Adult Psychiatrist – Hyderabad

Dr. Monica Singh, Predictive Homeopath and General Physician – Bangalore
Predictive Homeopath and General Physician
These engagements are intended to support clinical feedback, workflow evaluation, and product development.

3. Kolkata Development Centre Partnership
NeuralClinic Ai has confirmed a collaboration with the Kolkata Development Centre focused on impact collaboration and product co-creation.
The centre is led by Dr. Anjan Bhattacharya, Consultant Developmental Paediatrician at Apollo Multispeciality Hospital and Founder & Director of Nabajatak Child Developmental Centre.
The multidisciplinary team includes:
Dr. Jewel Chakraborty
Director, Nabajatak Child Development Centre
Megha Goenka
Psychologist & Early Interventionist
Mr. Bishwajit Ghosh
CEO
The collaboration provides access to a multidisciplinary developmental-care environment spanning developmental pediatrics, occupational therapy, psychology, parent support, and clinician training, with centres in Kolkata and Asansol, West Bengal.
For NeuralClinic Ai, this creates an opportunity to incorporate real-world clinical workflows and specialist feedback into ongoing product development.

4. International Clinical Engagement
Kuwait

Dr. Rozina Khan
NeuralClinic Ai has confirmed engagement with Dr. Rozina Khan, an MBBS, DCH, Certified Autism Specialist (CAS), BCBA, and QAB candidate, with experience in child health advocacy and autism-focused care.
The engagement provides an opportunity to evaluate the application of NeuralClinic Ai within autism and developmental-care workflows in Kuwait and gather additional clinical and product feedback.

5. Investment & Strategic Support
LvlUp Ventures
LvlUp Ventures has invested in NeuralClinic Ai and established a strategic support relationship with the company.
The relationship is supporting NeuralClinic Ai across product development, market validation, and commercialization activities.
SAFE Round
NeuralClinic Ai has opened a:
US$1.2 million SAFE round US
$12 million post-money valuation
Current Investor Pipeline
- US$100K+ in committed investment
- US$400K in additional soft commitments
- Additional angel investors currently evaluating participation
Total current commitment / soft-commitment pipeline: US$500K+

6. What We Are Building
NeuralClinic Ai is designed around a continuous developmental-care workflow:
Identify → Review → Plan → Monitor → Adapt
The platform currently focuses on:
- AI-assisted developmental screening
- Multimodal behavioral analysis
- Clinician decision support
- Personalized therapy planning
- Clinical documentation
- Longitudinal progress tracking
- Parent and family engagement
- Care coordination
- EHR integration
- Voice-enabled workflows
The product is being developed to support clinicians and care providers rather than replace clinical decision-making.

7. Clinical & Product Collaboration Opportunities
NeuralClinic Ai is currently exploring collaborations with:
Pediatricians | Developmental Pediatricians | Child Psychiatrists | Psychologists | SLPs | OTs | Behavioral Therapists | Special Educators | Developmental Researchers
Current areas of collaboration include:
- Early-adopter deployments
- Product feedback and clinical workflow refinement
- Clinical collaboration and real-world product feedback
- Provider onboarding and adoption
- Research and clinical Validation
- Developmental-care workflow co-creation

8. What Comes Next
Our immediate priority is to convert growing clinical engagement into structured provider collaborations and deployments while continuing product refinement and clinical validation.
Current Execution Path
Clinical engagment → Clinical colloboration → Early adoption & Deployment→ Product refinement → Clinical validation→ Scale
The September 2026 progress represents an expansion of NeuralClinic Ai’s clinical network, provider pipeline, international engagement, and investor support.
Our next phase is focused on turning these relationships into measurable deployments, structured clinical feedback, and repeatable adoption pathways.
NeuralClinic Ai Corporation
AI-Powered Clinical Intelligence for Developmental Care
Supporting:
Pediatricians • Developmental Pediatricians • Therapists • Psychiatrists • Psychologists • Clinics • Hospitals • Institutes • Healthcare Organizations
Understood early. Supported rightly.